Nottingham Clinical Trials Unit
The University of Nottingham
University of Nottingham
  • Print

Nottingham Clinical Trials Unit secures £1 million investment for expansion

The Nottingham Clinical Trials Unit (NCTU) has secured a £1 million investment in staff from the University Strategic Development Fund, with additional investment from Nottingham University Hospitals NHS Trust.

The Unit’s investment plans to build on the unit’s current strengths and will provide capacity and academic leadership to focus on specific areas where NCTU can generate world leading research (and which are aligned with research priorities of the School of Medicine, University, local NHS Trust and funders), including collaborating with the new NIHR Biomedical Research Centre supporting translational research and early phase clinical trials.

The award would enable the NCTU to create six new academic posts over the next year, providing succession planning and sustainability. The increase in funded projects, teaching and training, would be supported by three new administrative staff also appointed over the next year. (These posts will be advertised on the University's Jobs page.)


Investment objectives

NCTU is recognised nationally and internationally as a centre of excellence for multicentre clinical trials, and is a UK Clinical Research Collaboration registered Clinical Trials Unit. The NCTU's mission is to provide a flourishing and supportive environment in which we:

  1. Conduct high quality, high impact randomised trials that address important questions to improve health and well-being
  2. Develop the skills and careers of people interested in clinical trials research, growing capacity for the future
  3. Contribute to research to improve the quality and efficiency of trials

Following our SDF award, our aim is to establish the Unit as a world leading clinical trials unit by: 

  • Increasing high impact, margin-generating, multicentre clinical trials of importance to patients, their families and the NHS
  • Expanding our portfolio in strategic areas where we have potential to be world leading, and which align with research priorities within the School of Medicine and local NHS Trusts
  • Making Nottingham a highly attractive place to do health services research, thus attracting high quality ambitious collaborations and researchers, and retaining excellent staff.
  • Expanding capacity, expertise and reputation in medical statistics and clinical trials research
  • Developing a PhD programme which includes clinical trial methodology, health services research, medical statistics and translational research.  
  • Developing a programme of short courses and workshops in clinical trials
  • Enhancing existing partnerships with the NHS


Exciting times

This is an exciting and challenging phase for the NCTU, and for the Faculty of Medicine and Health Sciences and local trusts, where an increased focus on clinical research will bring a step-change in activity and impact in Nottingham.

Not only has the NCTU achieved significant investment but the NIHR Nottingham Biomedical Research Centre, led by Director Professor Ian Hall, is also due to open in April 2017.  This will bring in a step-change in the breadth and depth of early translational research across five specific themes (gastrointestinal and liver disorders, hearing loss, musculoskeletal diseases, respiratory medicine and mental health technology), with imaging as a cross-cutting theme. The newly formed BRC and the NCTU will work closely together to build on early translational research expertise within Nottingham to enable them to progress to large-scale multi-centre clinical trials.

Overall this will benefit the University’s core activities through additional large scale collaborative research grants, better Research Excellence Framework outputs, engagement with patients and the public, attracting post-doctoral and postgraduate fellows and recruiting and retaining high quality staff.


Posted on Thursday 27th October 2016

Nottingham Clinical Trials Unit

General enquiries
Telephone: +44 (0)115 8231600